Regulatory comments

KAW letter to the FDA's Dr, Sharfstein explaining its legal authority to act on antibiotic resistance issue.

KAW comments to FDA docket regarding the use of distillers grains as animal feed.

Comments to the FDA regarding the North American Bioproducts Corp. (NABC) Food Additive Petition for Erythromycin Thiocyanate (Animal Use) and recommending that the FDA not approve the addition of the critically important human drug erythromycin to animal feed due to the risk to public health from the development of antimicrobial resistance.  

Which obligations do States bear in the context of private sector participation in the provision of water and sanitation services? What should the regulatory framework put into place by States provide for? Apart from regulation, what additional measures, structures and institutions are necessary?

IATP's Dr. Steve Suppan testified before the Hearing on Nanotechnologies, Housing and Public Health Committee at the Minnesota House of Representatives. He shared IATP's views about some of general regulatory and legislative challenges presented by nanotechnologies.

A comment from the Institute for Agriculture and Trade Policy to the UN High Level Task Force on responding to the global food crisis.